Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04619992 · ClinicalTrials.gov registry record
Consumer Evaluation of Intermittent Catheter Product Modifications
A clinical trial, sponsored by Hollister Incorporated.
- Completed
- Registry status
- 62
- Enrollment target
NCT04619992: Completed study, sponsored by Hollister Incorporated.
NCT04619992 is a clinical trial that has completed, run by Hollister Incorporated. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04619992 has completed, sponsored by Hollister Incorporated.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
This study aims to collect feedback from hydrophilic intermittent catheter end-users to assess user acceptance of the test hydrophilic intermittent catheter and generate evidence to support commercial marketing objectives.
Primary Outcome
Users will rate if Test device is an acceptable alternative to currently marketed device. Acceptability will be rated via a standard 5-point Likert agreement scale. Agreement signifies Test catheter is an acceptable alternative to currently marketed catheter.
Interventions
- DEVICE Currently marketed Hydrophillic Intermittent Catheter
- DEVICE Test Hydrophilic Intermittent Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2020-10-14 |
| Est. Completion | 2021-08-17 |
What the finished NCT04619992 record still lists
NCT04619992 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Currently marketed Hydrophillic Intermittent Catheter is the first listed.
NCT04619992 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04619992 about?
NCT04619992 is a clinical study titled "Consumer Evaluation of Intermittent Catheter Product Modifications". This study aims to collect feedback from hydrophilic intermittent catheter end-users to assess user acceptance of the test hydrophilic intermittent catheter and generate evidence to support commercial marketing objectives.
What is the current status of trial NCT04619992?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2020-10-14. Estimated completion is 2021-08-17.
What interventions are being tested in trial NCT04619992?
The interventions under investigation include: Currently marketed Hydrophillic Intermittent Catheter (DEVICE), Test Hydrophilic Intermittent Catheter (DEVICE).
Who is sponsoring clinical trial NCT04619992?
This trial is sponsored by Hollister Incorporated, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI